CircRNA circTRAF3 promotes nasopharyngeal carcinoma metastasis through targeting miR-203a-3p/AKT3 axis

Xing Fang1, Wei Huang2, Ping Wu1

  • 1Department of Otorhinolaryngology Head & Neck Surgery, Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.

Insights

Circular RNA circTRAF3 promotes nasopharyngeal carcinoma (NPC) metastasis by sponging miR-203a-3p, impacting the AKT3 pathway. Targeting this circRNA offers a potential therapeutic strategy for metastatic NPC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Distant metastasis remains the primary cause of mortality in nasopharyngeal carcinoma (NPC).
  • The underlying mechanisms driving NPC metastasis are not fully elucidated.
  • Circular RNAs (circRNAs) are emerging as critical regulators in various cancers, including NPC.

Purpose of the Study:

  • To investigate the biological function and molecular mechanism of circRNA circTRAF3 in NPC metastasis.
  • To determine the association between circTRAF3 expression and patient survival.
  • To explore circTRAF3 as a potential therapeutic target for metastatic NPC.

Main Methods:

  • Quantitative real-time PCR to assess circTRAF3 expression.
  • In vitro assays (cell proliferation, invasion, apoptosis) and in vivo studies (tumorigenesis).
  • Mechanism studies involving RNA immunoprecipitation and luciferase reporter assays to elucidate the circRNA-miRNA-mRNA interaction.

Main Results:

  • Increased circTRAF3 expression correlates with advanced NPC metastasis and poorer patient survival.
  • Knockdown of circTRAF3 significantly inhibited NPC cell proliferation and invasion, while promoting apoptosis in vitro and in vivo.
  • circTRAF3 acts as an oncogene by sponging miR-203a-3p, thereby relieving its inhibition on AKT3 expression.

Conclusions:

  • circTRAF3 functions as an oncogene in nasopharyngeal carcinoma progression and metastasis.
  • The identified circTRAF3/miR-203a-3p/AKT3 pathway represents a novel regulatory axis in NPC.
  • This pathway holds promise as a potential therapeutic target for overcoming distant metastasis in NPC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K